Stockscreener 앱 받기
9.69
3.97%
0.37
시간 외 거래:
9.94
0.25
+2.58%
전일 마감가:
$9.32
열려 있는:
$9.4
하루 거래량:
1.76M
Relative Volume:
1.68
시가총액:
$763.28M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.10%
1개월 성능:
-31.86%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$9.39
$9.947
1주일 범위
$9.21
$9.947
52주 변동 폭
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
명칭
Niagen Bioscience Inc
전화
310-388-6706
주소
10900 WILSHIRE BLVD, LOS ANGELES
NAGE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.69 | 734.13M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 개시 | Canaccord Genuity | Buy |
| 2022-08-16 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-08-11 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 개시 | ROTH Capital | Buy |
| 2019-10-16 | 개시 | Oppenheimer | Outperform |
| 2019-02-14 | 개시 | B. Riley FBR | Buy |
| 2017-11-27 | 재개 | H.C. Wainwright | Buy |
| 2017-09-25 | 개시 | Ladenburg Thalmann | Buy |
| 2017-01-03 | 개시 | Rodman & Renshaw | Buy |
모두보기
Niagen Bioscience Inc 주식(NAGE)의 최신 뉴스
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionAdvanced Screener Report With Low Risk - jammulinksnews.com
What is the dividend policy of Niagen Bioscience Inc. stockExceptional gains - jammulinksnews.com
What is Niagen Bioscience Inc. company’s growth strategyAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Should I hold or sell Niagen Bioscience Inc. stock in 2025Invest confidently with professional guidance - jammulinksnews.com
How does Niagen Bioscience Inc. generate profit in a changing economyMaximize your investment portfolio’s performance - jammulinksnews.com
Niagen Bioscience Inc. Stock Analysis and ForecastHigh-yield capital appreciation - PrintWeekIndia
What drives Niagen Bioscience Inc. stock priceFree Market Volatility Navigation Tips - PrintWeekIndia
Does Niagen Bioscience Inc. stock pay reliable dividendsTriple-digit return opportunities - jammulinksnews.com
Is Niagen Bioscience Inc. a good long term investmentOutstanding growth strategies - Autocar Professional
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Niagen Bioscience to Report Second Quarter 2025 Financial Result - GuruFocus
Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - Business Wire
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap dropped US$129m last week; individual investors who hold 33% were hit as were institutions - simplywall.st
What analysts say about Niagen Bioscience Inc. stockFree Consultation - Autocar Professional
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Niagen Bioscience (NASDAQ:NAGE) Shares Down 4%Time to Sell? - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Analysts Set Niagen Bioscience, Inc. (NASDAQ:NAGE) Target Price at $13.22 - Defense World
How Niagen Bioscience Inc. stock performs during market volatilityROI Driven Alerts - Newser
What makes Niagen Bioscience Inc. stock price move sharplyFree Stock Market Group - Newser
Why Niagen Bioscience Inc. stock attracts strong analyst attentionTop Growth Low Risk Stocks - Newser
Niagen Bioscience Inc (NAGE) 재무 분석
Niagen Bioscience Inc (NAGE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Niagen Bioscience Inc 주식 (NAGE) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel |
Mar 07 '25 |
Buy |
7.86 |
273 |
2,146 |
2,251 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
1.32%
1.06%
자본화:
|
볼륨(24시간):